World Journal of Gastrointestinal Oncology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Liang J, Bai Y, Ha FS, Luo Y, Deng HT, Gao YT. Combining local regional therapy and systemic therapy: Expected changes in the treatment landscape of recurrent hepatocellular carcinoma. World J Gastrointest Oncol 2023; 15(1): 1-18 [PMID: 36684055 DOI: 10.4251/wjgo.v15.i1.1]
URL:	https://www.wjgnet.com/1948-5204/full/v15/i1/1.htm

(173) (163) (0) (0) (0) (9) (2) (7211) (13)

Number	Citing Articles
1	Yaxuan Pang, Jing Zhang, Yanan Mou, Yanan Zhai, Nianjun Liu, Liang Yin. Intra-ablational and peri-ablational radiomics based on post-RFA gadoxetic acid disodium-enhanced MRI for predicting short-term prognosis in hepatocellular carcinoma. Abdominal Radiology 2026; doi: 10.1007/s00261-026-05542-w
2	Changlong Hou, Baizhu Xiong, Lei Zhou, Yipeng Fei, Changgao Shi, Xianhai Zhu, Tao Xie, Yulin Wu. Transarterial chemoembolization with molecular targeted therapies plus camrelizumab for recurrent hepatocellular carcinoma. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12144-6
3	Ming-Zhi Hao, Hai-Lan Lin, Yu-Bin Hu, Qi-Zhong Chen, Zhang-Xian Chen, Lin-Bin Qiu, Duan-Yu Lin, Hui Zhang, De-Chun Zheng, Zhu-Ting Fang, Jing-Feng Liu. Combination therapy strategy based on selective internal radiation therapy as conversion therapy for inoperable giant hepatocellular carcinoma: A case report. World Journal of Gastrointestinal Oncology 2025; 17(3): 100861 doi: 10.4251/wjgo.v17.i3.100861 Abstract(378) \| Core Tip(405) \| Full Article(HTML)(1679) \| Full Article (PDF)-6723K(226) \| Full Article with Cover (PDF)-7010K(122) \| Full Article (XML)-84K(121) \| Audio-787K(29) \| Peer-Review Report-223K(101) \| Answering Reviewers-79K(116) \| Times Cited (0) \| Total Visits (2525) \| Open
4	Meng Li, Yumin Jiang, Lin Gong, Ruitao Sun, Aoyun Hao, Kun Liu, Kunye Luan, Zheng Jia, Shimei Zhang, Kui Liu, Bin Tan, Weiyu Hu, Chao Qu, Jingyu Cao. Development and Validation of a Machine Learning-Based Individualized Model to Predict TKI Benefit in Postoperative Recurrent HCC. Journal of Hepatocellular Carcinoma 2026; doi: 10.2147/JHC.S599142
5	Beichuan Pang, Bangyou Zuo, Liang Huang, Xinyu You, Tao Liu, Jianjie Hao, Chengxiang Yuan, Chong Yang, Wan Yee Lau, Yu Zhang. Real-world efficacy and safety of TACE-HAIC combined with TKIs and PD-1 inhibitors in initially unresectable hepatocellular carcinoma. International Immunopharmacology 2024; 137 doi: 10.1016/j.intimp.2024.112492
6	Yutao Chen, Desheng Chen, Zhixing Liang, Haoyuan Yu, Haobin Sun, Yongwei Hu, Peng Jiang, Mingshen Zhang, Linsen Ye, Hua Li. Immune checkpoint inhibitors in hepatocellular carcinoma therapy: resistance mechanisms, liver transplantation challenges and management strategies. Cancer Drug Resistance 2025; doi: 10.20517/cdr.2025.120
7	Junning Liu, Guangnian Zhang, Linfeng Yang, Duan Yan, Jiahui Yu, Song Wei, Jijiang Li, Pengsheng Yi. Salvage liver transplantation versus curative treatment for patients with recurrent hepatocellular carcinoma: A systematic review and meta-analysis. European Journal of Surgical Oncology 2024; 50(7) doi: 10.1016/j.ejso.2024.108427
8	Ling Li, Wenjing Xie, Haixia Sun, Houqiang Yu, Cai Wang, Min Zheng, Peng Shi, Hongan Tian, Tongqiang Xiong. Synergistic Effect of Doxorubicin-Thermo-Iodized Oil Pickering Emulsions on the Interventional Embolization-Chemotherapy- Immunity of VX2 Rabbit Liver Cancer. International Journal of Nanomedicine 2026; doi: 10.2147/IJN.S569851
9	Noura A A Ebrahim, Thoraya A Farghaly, Ahmed Abdo El-Sherif, Ahmed M Fahmy, Moamen O Othman, Neveen S Tahoun, Omnia Mohamed Korany, Aya Arafat, Reham Oreaba, Soliman M A Soliman. Clinicopathological insights and management of liver metastases: Current advances and future perspectives. World Journal of Hepatology 2025; 17(10): 110026 doi: 10.4254/wjh.v17.i10.110026 Abstract(78) \| Core Tip(68) \| Full Article(HTML)(403) \| Full Article (PDF)-6918K(164) \| Full Article with Cover (PDF)-7225K(91) \| Full Article (XML)-290K(50) \| Audio-128K(39) \| Peer-Review Report-442K(38) \| Answering Reviewers-117K(44) \| Times Cited (2) \| Total Visits (834) \| Open
10	Yubo Jiang, Xiaofeng Dong, Yingying Zhang, Feiyan Su, Lei Zhao, Xuetao Shi, Jingtao Zhong. Navigating the complexities: challenges and opportunities in conversion therapy for advanced hepatocellular carcinoma. Clinical and Experimental Medicine 2025; 25(1) doi: 10.1007/s10238-025-01698-9
11	Mingqiang Liu. Effect of regorafenib combined with immunotherapy and arterial chemoembolization on the survival of patients with advanced hepatocellular carcinoma: a retrospective study. American Journal of Translational Research 2025; 17(3) doi: 10.62347/BXYO6569
12	Peijie Xia, Aibing Xu, Siyuan Tian, Honghua Huang, Miao Ouyang, Shengnan Huang, Hu Xu. Efficacy and Safety Analysis of Local-Systemic Combined Therapy Versus Systemic Therapy Alone in TACE-Resistant Hepatocellular Carcinoma Patients. Hepatitis Monthly 2026; 26(1) doi: 10.5812/hepatmon-168214

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.